Navigation Links
Biosimilars of Rituxan, MabThera, Herceptin and Erbitux will Erode $8.2 Billion in U.S. and European Sales in 2018
Date:9/15/2009

WALTHAM, Mass., Sept. 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018. Biosimilars of these three branded agents are forecasted to erode $8.2 billion in U.S. and European sales in 2018 but they are expected to capture only $4.6 billion in sales due to their lower prices.

"Biosimilars of the five brands covered in this report (Rituxan/MabThera, Erbitux, Herceptin, Amgen's Neupogen and Neulasta) will erode $34.3 billion in brand sales during our 2008-2018 forecast period across the U.S. and Europe and save health care systems $17.3 billion in the process," stated Michael Malecki, Ph.D., analyst and product manager at Decision Resources.

The new special report entitled Biosimilars: G-CSFs and Monoclonal Antibodies in Oncology also finds that oncologists are expected to demand clinical data for biosimilars demonstrating equivalence in multiple subpopulations. That is, although a biosimilar may be labeled for use in multiple subpopulations, oncologists will not feel comfortable prescribing a biosimilar without clinical validation.

Over time, oncologists are expected to become more comfortable using biosimilars in subpopulations and/or indications for which the reference product is approved but not clinically validated. In order to slow the growth of physician comfort in this regard, makers of branded biologics should emphasize the proven efficacy records of their agents and the importance of using a fully validated therapy for patients with life-threatening disease.

"Although surveyed oncol
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GPhA Statement on Introduction of H.R. 1548, The Pathway for Biosimilars Act
2. Decision Resources White Paper Discusses Increasing Reality of Biosimilars and their Impact on Biologics Market
3. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
4. Routine Testing Would Improve Herceptin Use in Breast Cancer
5. Mathematical modeling predicts response to Herceptin
6. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
7. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
8. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
9. Erbitux May Help Some With Colorectal Cancer
10. Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
11. Erbitux Works Well for Two-Thirds of Colon Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Business Development. Mr. Mooney, who has ... treatment field, will be responsible for developing new strategic ... of MAP’s core products and new initiatives. , Prior ...
(Date:5/5/2015)... Pa (PRWEB) May 05, 2015 The ... of accelerated aging that correlate with slower information processing, ... Pittsburgh Graduate School of Public Health . , ... patients with type 1 diabetes for cognitive difficulties. If ... their diabetes. The study, funded by the National ...
(Date:5/5/2015)... On May, 5, 2015, My Positive Perspective host Jason ... alternatives for youngsters to do this summer. As the episode ... for starting a summer camp and how is it going ... Once Upon a Party and I come to children’s birthday ... scripture. We play games, sing, and dance and have a ...
(Date:5/5/2015)... 2015 With Mother's Day, graduation ... of the country's leading organic vegetable brands, knows ... across the country. What to eat? There’s no ... or spend hours browsing Pinterest – Josie's Organics ... . , The new recipes are sophisticated ...
(Date:5/5/2015)... Oklahoma (PRWEB) May 05, 2015 Don’t ... the money for a fitness membership? Don’t know which ... of these obstacles in order to help members achieve ... life. Live Streaming Fitness, an educational, caused-based wellness company, ... offers live streaming fitness classes led by certified trainers, ...
Breaking Medicine News(10 mins):Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3
... on the latest diet pill under the brand name Alli, there ... down their weight. Alli has been given the status of over ... is said to block the absorption of fat by the body. ... side effects of Alli. ,In the Indian scenario, there ...
... may be smiling. Researchers have given their opinion- Nature’s way ... upon by the mother, in spite of it being unnecessary. ... Canadian Medical Association Journal, the risks encountered by a woman ... not advising it, is three times higher than that of ...
... may sometimes cause precancerous tissues to become fully malignant. ... deadly process. ,Typically, the "innate" immune system's Pac-Man-like ... microbes when receptors on their surface receive a signal ... produced by a B cell in the separately evolved ...
... of efavirenz 600mg tablets (Stocrin) for developing countries that qualify ... ,It is the second price cut in a year, ... cheaper than a generic import in Thailand, where a compulsory ... India. ,For least developed countries and medium ...
... of exercise and play but can pose a greater injury ... new Swedish study. ,The increase of trampoline-related injuries ... that could occur, Ulf Bjornstig of the Umea University Hospital ... ,The most common injuries were, however, sprains and broken bones ...
... the needle in the haystack as years of scientific ... hitherto unknown genetic material that causes autism. ... and treatment of autism has been met with considerable ... an international team from 8 countries and led by ...
Cached Medicine News:Health News:Inflammation can Lead to Cancer 2Health News:New Gene Linked to Autism Discovered 2
(Date:5/5/2015)... 05, 2015 Research and Markets ( ... "Home Healthcare Global Market - Forecast to 2020" ... market is expected to reach more than $300+ billion ... The home healthcare equipment market is expected to grow ... market. Home healthcare is gaining a tremendous attention over ...
(Date:5/5/2015)... 5, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... $4.0 million for the three months ended March 31, ... of $22.6 million for the same period in 2014.  ... revenue from milestone payments earned from its partners compared ... basis, Isis reported a loss from operations of $9.3 ...
(Date:5/5/2015)... 2015 Big Market Research presents a detailed ... Europe , ( France , Germany ... , UK) and Japan . Current scientific views ... provides the 5-year test volume and sales forecasts by country for ... Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed ...
Breaking Medicine Technology:Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 132015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
Information on diagnosis and management of 500 common or important medical and surgical disorders....
The workhorse electric system....
... BD Safety Knife with BD Xstar Blade ... that protects the blade in prodedure and ... based on a grind-less process for manufacturing ... outstanding sharpness and consistency. The arch ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
Medicine Products: